ACIPHEX

Active ingredients

The drug ACIPHEX contains one active pharmaceutical ingredient (API):

UNII 3L36P16U4R - RABEPRAZOLE SODIUM

Rabeprazole belongs to the class of anti-secretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonist properties, but suppress gastric acid secretion by the specific inhibition of the H+/K+ -ATPase enzyme (the acid or proton pump).

Read about Rabeprazole

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
ACIPHEX SPRINKLE Delayed-release capsule
Structured Product Labeling (SPL/PLR)
US
ACIPHEX Delayed-release tablet
Structured Product Labeling (SPL/PLR)
US

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
A02BC04
Rabeprazole
A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC04

Authorization and marketing

This brand name is authorized in the following countries: United States South Africa

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
US
FDA, National Drug Code
Identifier(s): 23594-205, 23594-210, 62856-243
ZA
Health Products Regulatory Authority
Identifier(s): A39/11.4.3/0468, A39/11.4.3/0469